精优药业(00858.HK)：谢毅辞任行政总裁
EXTRAWELL PHAREXTRAWELL PHAR(HK:00858) Ge Long Hui·2025-12-30 12:16

Group 1 - The core point of the article is that Jingyou Pharmaceutical (00858.HK) is restructuring its management to enhance corporate governance and meet development needs, effective January 1, 2026 [1] - Xie Yi will resign as CEO to focus on formulating company strategy but will continue as Chairman of the Board and Executive Director [1] - Executive Director Guo Yi will be appointed as the new CEO [1]